SPRO compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

SPROSpero Therapeutics, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

SPROSpero Therapeutics, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SPRO 7

PFEPfizersupplier

GSKGSKcustomer

—Meijiunlistedsupplier

—Cantab Anti-Infectivesunlistedsupplier

3 more · SPRO chain ›

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›

SPROSpero Therapeutics, Inc.

1.02▲+0.05%

Mkt cap$59.4MRevenue$258,000Q1 FY26Revenue$67MFY25

LLYELI Lilly & Co

1,366.46▲+0.13%

Regular sessionNov 6 '26

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

Regular sessionNov 6 '26

SPROSpero Therapeutics, Inc.

LLYELI Lilly & Co

1.02▲+0.05%

Price

1,366.46▲+0.13%

$59.4M

Mkt cap

$1.2T

Q1 FY26$258,000

Revenue

$24.4BQ3 FY26

FY25$67M

Revenue

$65.2BFY25

SPRO1.02▲+0.05%vsLLY1,366.46▲+0.13%Regular sessionNov 6 '26